drugset / Trial / NCT02249728

Absorption, Metabolism and Excretion Study of [14C]PBT2 and Absolute Bioavailability of PBT2

NCT02249728 ↗

Phase 1 Completed 6 enrolled Prana Biotechnology Limited
Non-randomizedSingle-groupOpen-labelBasic science

Summary

The purpose of the study is to investigate how the test drug, PBT2, is taken up, broken down and removed from the body when given as an oral capsule, a radiolabelled oral suspension and a radiolabelled intravenous injection.

Timeline

Start
2014-06
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject PBT2 Small molecule — Intravenous

Indications

No indication recorded.